Fortis Healthcare Limited

NSE FORTIS.NS

Fortis Healthcare Limited Current Liabilities for the year ending March 31, 2024: USD 380.07 M

Fortis Healthcare Limited Current Liabilities is USD 380.07 M for the year ending March 31, 2024, a 119.08% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Fortis Healthcare Limited Current Liabilities for the year ending March 31, 2023 was USD 173.49 M, a 3.77% change year over year.
  • Fortis Healthcare Limited Current Liabilities for the year ending March 31, 2022 was USD 167.18 M, a -0.72% change year over year.
  • Fortis Healthcare Limited Current Liabilities for the year ending March 31, 2021 was USD 168.40 M, a -50.79% change year over year.
  • Fortis Healthcare Limited Current Liabilities for the year ending March 31, 2020 was USD 342.22 M, a -33.77% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
NSE: FORTIS.NS

Fortis Healthcare Limited

Description

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetes/endocrinology, emergency medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties. As of March 31, 2022, it operated a network of 26 hospitals with approximately 4,300 operational beds. The company also operates approximately 426 diagnostics centers and laboratories; and 2,550 collection centers. The company was incorporated in 1996 and is based in Gurugram, India.

Similar companies

APOLLOHOSP.NS

Apollo Hospitals Enterprise Limited

USD 78.50

-0.28%

IPCALAB.NS

Ipca Laboratories Limited

USD 16.64

-0.86%

INDHOTEL.NS

The Indian Hotels Company Limited

USD 8.81

0.39%

GSPL.NS

Gujarat State Petronet Limited

USD 3.98

0.67%

GLENMARK.NS

Glenmark Pharmaceuticals Limited

USD 16.75

0.23%

StockViz Staff

February 2, 2025

Any question? Send us an email